ACM
DTIL icon

Aquilo Capital Management’s Precision BioSciences DTIL Stock Holding History

Aquilo Capital Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-726,149
Closed -$3.46M – 7
2025
Q1 		$3.46M Buy
726,149
+189,773
+35% +$966K 6.21% 6
2024
Q4 		$2.04M Buy
536,376
+154,573
+40% +$1.13M 3.08% 12
2024
Q3 		$3.42M Hold
381,803
– – 2.59% 12
2024
Q2 		$3.71M Sell
381,803
-3,637
-0.9% -$42.8K 3.58% 8
2024
Q1 		$5.23M Buy
+385,440
New +$4.72M 3.92% 9

Other funds holding DTIL

BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Aquilo Capital Management's DTIL Position: Q2 2025 in Review

Aquilo Capital Management sold out of Precision BioSciences (DTIL) in Q2 2025, closing a stake of 726,149 shares — an estimated $3.46M sold.

Aquilo Capital Management first reported a position in DTIL in Q1 2024 and held it in 5 quarters. The position peaked at $5.23M in Q1 2024. 52 funds tracked by Wall St. Rank hold DTIL as of Q2 2025.

  • Aquilo Capital Management reported no remaining Precision BioSciences position as of Q2 2025 after selling out during the quarter.
  • Aquilo Capital Management sold 726,149 Precision BioSciences shares in Q2 2025, an estimated $3.46M.
  • Aquilo Capital Management first reported a position in Precision BioSciences in Q1 2024 and held it in 5 quarters.
  • Aquilo Capital Management's Precision BioSciences position peaked at $5.23M in Q1 2024.
  • 52 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2025.

Based on Aquilo Capital Management's 13F filing for Q2 2025.